Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Sep 07 2022

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/press-release-sep-07-2022-2

Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Replay · Oct 23Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call

Release

Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 07-Sep-2022 titled "Dr. Reddy's Laboratories announces the launch of Lenalidomide Capsules in the U.S. with two of six strengths eligible for first-to-market, 180-day exclusivity.

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases